Announcement

Senzer is responding to the Coronavirus (COVID-19) outbreak, working with physicians and health agencies to develop inhaled treatment options.
Read more

Unlocking the full potential of inhalation technologies and therapies

Senzer develops, manufactures and licenses pioneering respiratory products intended for the delivery of pharmaceutical formulations

Breaking news

Senzer’s Respiratory Device Wins Red Dot Design Award

Read More

A unique respiratory delivery system

Senzer is a pharmaceutical company that develops, manufactures and licences innovative respiratory devices designed to deliver a range of pharmaceutical molecules, including cannabinoids, safely and effectively.

Senzer’s unique inhalation platform allows a fast uptake of these molecules compared to oral ingestion, and can be easily self-administered by patients. Our products aspire to make a real and tangible difference to a patient’s quality of life by advancing the treatment options available.

At Senzer, we’re discovering new ways to make life better. From research and development through to commercialisation, we explore, innovate and modify our technologies to complement and enhance existing conventional and alternative treatments to ensure we are a leader in this field.

Recent News

Jun 26 2020
Senzer Limited - Logo
Senzer Limited - Logo
Senzer Limited
Press release

Senzer Strengthens Board and Executive Team Ahead of Commercialisation Phase

Highlights Barbara Staehelin  becomes Chairman, and two new non-executive directors appointedAdam Kelliher, Senzer's former Chairman, becomes Chief Executive Officer (CEO) to align commercial strategyFormer CEO and founder Alex Hearn becomes Deputy Chairman and will remain fully engaged with the CompanyExecutive team expanded with new Chief Operating Officer (COO), Chief Medical Officer (CMO) and General Counsel Senzer, a...

Read More
Jun 23 2020
Senzer Limited - Logo
Senzer Limited - Logo
Senzer Limited
Press release

Senzer’s Respiratory Device Wins Red Dot Design Award

Senzer's unique cannabinoid inhaler has notched up its fourth major design prize -- the prestigious Red Dot Award -- which is bestowed on products that are both aesthetic and show 'incomparable functionality', the Company said today. Senzer's entry – its Systemic inhaled Delivery Device, SiDD™ – won in the healthcare category of the Red Dot Award, in which some...

Read More
May 14 2020
Senzer Limited - Logo
Senzer Limited - Logo
Senzer Limited
Press release

Senzer to Create Targeted Anti-viral Treatments for COVID-19

Senzer Pharmaceuticals, a UK company involved in the development, manufacture and licencing of pioneering respiratory products for pharmaceutical formulations, has launched a Critical Care Division, which will utilise its expertise in respiratory pharmaceuticals to create targeted anti-viral treatments for COVID-19. The Critical Care Division is working on formulating two specific medicines, with anti-viral properties, to...

Read More